ClinicalTrials.govpublic full text
Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
multiple myeloma and plasma cell neoplasm, refractory multiple myeloma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 888428
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.